• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of psychosis remission in psychotic disorders that co-occur with substance use.与物质使用共病的精神障碍中精神病性症状缓解的预测因素。
Schizophr Bull. 2006 Oct;32(4):618-25. doi: 10.1093/schbul/sbl007. Epub 2006 Jul 27.
2
Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.有物质滥用和无物质滥用的精神病患者的症状及终生治疗经历
Nord J Psychiatry. 2004;58(3):237-42. doi: 10.1080/08039480410006296.
3
Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.伴有物质使用的早期原发性精神障碍与物质所致精神病之间的差异。
Arch Gen Psychiatry. 2005 Feb;62(2):137-45. doi: 10.1001/archpsyc.62.2.137.
4
The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.首次发作精神病治疗后认知和症状缓解对功能结局的相对贡献。
J Clin Psychiatry. 2014 Jun;75(6):e566-72. doi: 10.4088/JCP.13m08606.
5
Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.患有严重精神疾病且同时存在物质使用障碍的患者中苯二氮䓬类药物的使用与滥用情况。
Psychiatr Serv. 2003 Oct;54(10):1395-401. doi: 10.1176/appi.ps.54.10.1395.
6
Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.首发精神病中症状缓解定义的检测对预测 2 年时的功能结局。
Schizophr Bull. 2010 Sep;36(5):1001-8. doi: 10.1093/schbul/sbp007. Epub 2009 Mar 25.
7
Long-term course of substance use disorders among patients with severe mental illness.严重精神疾病患者物质使用障碍的长期病程
Psychiatr Serv. 1995 Mar;46(3):248-51. doi: 10.1176/ps.46.3.248.
8
Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis.伴有物质使用和物质所致精神病的早期原发性精神障碍的稳定性
Br J Psychiatry. 2007 Feb;190:105-11. doi: 10.1192/bjp.bp.105.015784.
9
Psychotic patients with unclear diagnoses. A descriptive analysis.诊断不明的精神病患者。一项描述性分析。
J Nerv Ment Dis. 1995 Apr;183(4):207-13. doi: 10.1097/00005053-199504000-00004.
10
A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.一项针对精神分裂症谱系障碍和药物滥用患者的为期12个月的前瞻性随访研究:精神症状和药物使用的变化。
Schizophr Res. 2006 Mar;83(1):65-75. doi: 10.1016/j.schres.2005.11.019. Epub 2006 Feb 7.

引用本文的文献

1
Psychosis Prognosis Predictor: A continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis.精神病预后预测器:对首发精神病治疗结果的连续且感知不确定性的预测。
Acta Psychiatr Scand. 2025 Mar;151(3):280-292. doi: 10.1111/acps.13754. Epub 2024 Sep 18.
2
Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors.首发精神病的长期结局:一项对症状、功能和个人康复及其基线预测因素的自然随访 21 年研究。
Schizophr Bull. 2022 May 7;48(3):631-642. doi: 10.1093/schbul/sbab145.
3
Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study.埃塞俄比亚阿姆哈拉地区综合专科医院随访的精神分裂症谱系障碍患者的终生复发情况及其相关因素:一项横断面研究。
Int J Ment Health Syst. 2021 May 6;15(1):42. doi: 10.1186/s13033-021-00464-0.
4
Symptomatic and Functional Remission in Young Adults with a Psychotic Disorder in a Rehabilitation Focused Team.以康复为重点的团队中患有精神障碍的年轻成年人的症状性和功能性缓解
Community Ment Health J. 2020 Apr;56(3):549-558. doi: 10.1007/s10597-019-00512-7. Epub 2019 Dec 9.
5
Encephalopathy or Psychosis?脑病还是精神病?
Innov Clin Neurosci. 2016 Dec 1;13(11-12):41-42. eCollection 2016 Nov-Dec.
6
The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.物质使用对首发精神病患者 10 年结局的影响。
Schizophr Bull. 2017 Jul 1;43(4):843-851. doi: 10.1093/schbul/sbw179.
7
Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.预测精神分裂症患者的功能缓解:一项关于症状缓解、社会心理缓解、功能及临床结局的横断面研究
Neuropsychiatr Dis Treat. 2015 Sep 10;11:2339-48. doi: 10.2147/NDT.S87335. eCollection 2015.
8
Personalized risk assessment of drug-related harm is associated with health outcomes.药物相关伤害的个性化风险评估与健康结果相关。
PLoS One. 2013 Nov 6;8(11):e79754. doi: 10.1371/journal.pone.0079754. eCollection 2013.
9
Empirically Based Psychosocial Therapies for Schizophrenia: The Disconnection between Science and Practice.基于实证的精神分裂症心理社会治疗:科学与实践之间的脱节。
Schizophr Res Treatment. 2013;2013:792769. doi: 10.1155/2013/792769. Epub 2013 Apr 23.
10
Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).系统综述显示,在使用精神障碍觉察量表(SUMD)方面存在异质性。
Curr Psychiatry Rep. 2013 Jun;15(6):361. doi: 10.1007/s11920-013-0361-8.

本文引用的文献

1
Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.使用《精神疾病诊断与统计手册第四版》物质与精神障碍的精神病学研究访谈对物质使用者共病精神障碍的诊断。
Am J Psychiatry. 2006 Apr;163(4):689-96. doi: 10.1176/ajp.2006.163.4.689.
2
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.儿茶酚-O-甲基转移酶基因功能多态性对青少年期开始使用大麻所致成人精神病效应的调节作用:基因X环境相互作用的纵向证据
Biol Psychiatry. 2005 May 15;57(10):1117-27. doi: 10.1016/j.biopsych.2005.01.026.
3
Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.伴有物质使用的早期原发性精神障碍与物质所致精神病之间的差异。
Arch Gen Psychiatry. 2005 Feb;62(2):137-45. doi: 10.1001/archpsyc.62.2.137.
4
Value of early intervention in psychosis.精神病早期干预的价值。
Br J Psychiatry. 2004 Aug;185:172; author reply 172-3. doi: 10.1192/bjp.185.2.172.
5
Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.诊断药物滥用者的共病精神障碍:《物质与精神障碍精神科研究访谈》和《精神疾病诊断与统计手册》第四版结构化临床访谈西班牙语版本的效度
Am J Psychiatry. 2004 Jul;161(7):1231-7. doi: 10.1176/appi.ajp.161.7.1231.
6
Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses.前驱期起病后未经治疗的病程延长预示着首发精神病的预后。
Schizophr Bull. 2003;29(4):757-69. doi: 10.1093/oxfordjournals.schbul.a007045.
7
Duration of untreated psychosis: impact on 2-year outcome.未治疗精神病的持续时间:对两年结局的影响。
Psychol Med. 2004 Feb;34(2):277-84. doi: 10.1017/s0033291703001156.
8
Reducing the duration of untreated first-episode psychosis: effects on clinical presentation.缩短首发精神病性障碍未治疗期:对临床表现的影响
Arch Gen Psychiatry. 2004 Feb;61(2):143-50. doi: 10.1001/archpsyc.61.2.143.
9
Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients.慢性精神分裂症和分裂情感性障碍患者的精神病洞察力及康复情况。
J Psychiatr Res. 2004 Mar-Apr;38(2):169-76. doi: 10.1016/s0022-3956(03)00091-8.
10
Gender differences in schizophrenia.精神分裂症中的性别差异。
Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:17-54. doi: 10.1016/s0306-4530(02)00125-7.

与物质使用共病的精神障碍中精神病性症状缓解的预测因素。

Predictors of psychosis remission in psychotic disorders that co-occur with substance use.

作者信息

Caton Carol L M, Hasin Deborah S, Shrout Patrick E, Drake Robert E, Dominguez Boanerges, Samet Sharon, Schanzer Bella

机构信息

New York State Psychiatric Institute and the Department of Psychiatry, Columbia University, USA.

出版信息

Schizophr Bull. 2006 Oct;32(4):618-25. doi: 10.1093/schbul/sbl007. Epub 2006 Jul 27.

DOI:10.1093/schbul/sbl007
PMID:16873441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2632269/
Abstract

OBJECTIVE

To examine rates and predictors of psychosis remission at 1-year follow-up for emergency admissions diagnosed with primary psychotic disorders and substance-induced psychoses.

METHOD

A total of 319 patients with comorbid psychosis and substance use, representing 83% of the original referred sample, were rediagnosed at 1 year postintake employing a research diagnostic assessment. Remission of psychosis was defined as the absence of positive and negative symptoms for at least 6 months. Likelihood ratio chi-square tests and multivariate logistic regression were the main means of analysis.

RESULTS

Of those with a baseline diagnosis of primary psychotic disorder, 50% were in remission at 1 year postintake, while of those with a baseline diagnosis of substance-induced psychosis, 77% were in remission at this time point. Lower Positive and Negative Syndrome Scale (PANSS) symptom levels at baseline, better premorbid functioning, greater insight into psychosis, and a shorter duration of untreated psychosis predicted remission at 1 year in both diagnostic groups. No interaction effects of baseline predictors and diagnosis type were observed. A stepwise multivariate logistic regression holding baseline diagnosis constant revealed the duration of untreated psychosis (odds ratio [OR] = 0.97; 95% confidence interval [CI] = 0.95, 0.997), total PANSS score (OR = 0.98; 95% CI = 0.97, 0.987), Premorbid Adjustment Scale score (OR = 0.13; 95% CI = 0.02, 0.88), and Scale to Assess Unawareness of Mental Disorders unawareness score (OR = 0.84; 95% CI = 0.71, 0.993) as key predictors of psychosis remission.

CONCLUSIONS

The association of better premorbid adjustment, a shorter duration of untreated psychosis, better insight into psychotic symptoms, and lower severity of psychotic symptoms with improved clinical outcome, reported previously in studies of schizophrenia, generalizes to psychosis remission in psychotic disorders that are substance induced.

摘要

目的

研究因原发性精神障碍和物质所致精神障碍而紧急入院的患者在1年随访时的精神病缓解率及预测因素。

方法

共有319例合并精神病和物质使用的患者(占原始转诊样本的83%),在入院1年后采用研究诊断评估进行重新诊断。精神病缓解定义为至少6个月无阳性和阴性症状。似然比卡方检验和多因素逻辑回归是主要分析方法。

结果

基线诊断为原发性精神障碍的患者中,50%在入院1年后缓解,而基线诊断为物质所致精神障碍的患者中,77%在该时间点缓解。两个诊断组中,基线时较低的阳性和阴性症状量表(PANSS)症状水平、较好的病前功能、对精神病的更好洞察力以及较短的未治疗精神病持续时间可预测1年时的缓解情况。未观察到基线预测因素与诊断类型的交互作用。在保持基线诊断不变的逐步多因素逻辑回归分析中,未治疗精神病的持续时间(比值比[OR]=0.97;95%置信区间[CI]=0.95,0.997)、PANSS总分(OR=0.98;95%CI=0.97,0.987)、病前适应量表评分(OR=0.13;95%CI=0.02,0.88)以及精神障碍自知力评估量表的自知力评分(OR=0.84;95%CI=0.71,0.993)是精神病缓解的关键预测因素。

结论

先前在精神分裂症研究中报道的病前适应更好、未治疗精神病持续时间更短、对精神病症状的洞察力更好以及精神病症状严重程度更低与临床结局改善之间的关联,在物质所致精神障碍的精神病缓解中同样适用。